文献速递主动脉疾病

体积在小腹主动脉瘤监测中的作用

Role of volume in small abdominal aortic aneurysm surveillance.
PubMed 文献 · J Vasc Surg · 2021-10-14

基于非侵入性治疗腹主动脉瘤临床试验中250例基线最大横径3.5-5.0 cm且至少接受2次CT扫描的受试者,每约6个月复查CT共2年,分析体积增长的预测因素。结果显示平均体积增长约10.4 cm³/年,基线体积、迂曲度、最大横径、当前吸烟与体积增长相关。

要点

  • 小腹主动脉瘤平均体积年增长约10.4 cm³,即约10%。
  • 基线体积与最大横径仅中度相关,体积增长预测因素不同于直径。
  • 达修复阈值的动脉瘤体积跨度大,提示单用直径评估存在局限。

核心结论

  • 基线AAA体积与最大横径中度相关,平均体积年增长约10%。
  • 基线体积、迂曲度、最大横径、当前吸烟、血管紧张素II受体阻滞剂使用及糖尿病史可预测体积增长。

研究设计与样本

  • 研究纳入非侵入性治疗腹主动脉瘤临床试验中基线最大横径3.5-5.0 cm、至少2次CT扫描的受试者250例。
  • CT扫描约每6个月一次,持续2年,采用最大横径、体积与迂曲度建模生长。
  • 采用单因素与多因素后退法最小二乘回归评估体积增长相关因素。

主要发现

  • 基线最大横径解释基线体积变异的43%(P < .0001)。
  • 平均体积增长率为10.4 cm³/年(标准差8.8 cm³/年),平均体积变化+10.4%。
  • 基线体积解释体积增长变异的30%,最大横径解释13%。
  • 基线迂曲度更高的动脉瘤体积增长率显著更大(差值32.8 cm³/年;P < .0001)。
  • 单因素分析中血管紧张素II受体阻滞剂使用(差值-3.4 cm³/年;P = .02)与糖尿病史(差值-2.8 cm³/年;P = .04)与较低体积增长率相关。

关键数值与推荐

  • 多因素分析中基线体积、迂曲指数、当前吸烟及无糖尿病史仍与体积增长显著相关。
  • 达到最大横径修复阈值的动脉瘤体积范围:女性102-142 cm³(n = 5),男性105-229 cm³(n = 20)。

临床怎么用

  • 小AAA监测中除最大横径外可考虑结合体积与迂曲度评估增长风险。
  • 吸烟者体积增长更快,血管紧张素II受体阻滞剂使用和糖尿病史者增长较慢,可用于风险分层。

局限性

  • 研究对象来自特定临床试验人群,基线最大横径3.5-5.0 cm,结论外推需谨慎。
  • 达到修复阈值者样本量小(女性5例、男性20例),体积范围解释力有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Current management of small abdominal aortic aneurysms (AAAs) primarily involves serial imaging surveillance of maximum transverse diameter (MTD) to estimate rupture risk. Other measurements, such as volume and tortuosity, are less well-studied and may help characterize and predict AAA progression. This study evaluated predictors of AAA volume growth and discusses the role of volume in clinical practice. METHODS: Subjects from the Non-invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (baseline AAA MTD, 3.5-5.0 cm) with ≥2 computed tomography scans were included in this study (n = 250). Computed tomography scans were conducted approximately every 6 months over 2 years. MTD, volume, and tortuosity were used to model growth. Univariable and multivariable backwards elimination least squares regressions assessed associations with volume growth. RESULTS: Baseline MTD accounted for 43% of baseline volume variance (P < .0001). Mean volume growth rate was 10.4 cm3/year (standard deviation, 8.8 cm3/year) (mean volume change +10.4%). Baseline volume accounted for 30% of volume growth variance; MTD accounted for 13% of volume growth variance. More tortuous aneurysms at baseline had significantly larger volume growth rates (difference, 32.8 cm3/year; P < .0001). Univariable analysis identified angiotensin II receptor blocker use (difference, -3.4 cm3/year; P = .02) and history of diabetes mellitus (difference, -2.8 cm3/year; P = .04) to be associated with lower rates of volume growth. Baseline volume, tortuosity index, current tobacco use, and absence of diabetes mellitus remained significantly associated with volume growth in multivariable analysis. AAAs that reached the MTD threshold for repair had a wide range of volumes: 102 cm3 to 142 cm3 in female patients (n = 5) and 105 cm3 to 229 cm3 in male patients (n = 20). CONCLUSIONS: Baseline AAA volume and MTD were found to be moderately correlated. On average, AAA volume grows about 10% annually. Baseline volume, tortuosity, MTD, current tobacco use, angiotensin II receptor blocker use, and history of diabetes mellitus were predictive of volume growth over time.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Olson SL, Panthofer AM, Blackwelder W, et al. Role of volume in small abdominal aortic aneurysm surveillance. J Vasc Surg. 2021. PMID: 34655683. doi:10.1016/j.jvs.2021.09.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。